ISOFORM SELECTIVITY AND KINETICS OF MORPHINE 3- AND 6-GLUCURONIDATION BY HUMAN UDP-GLUCURONOSYLTRANSFERASES: EVIDENCE FOR ATYPICAL GLUCURONIDATION KINETICS BY UGT2B7
- 1 September 2003
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 31 (9) , 1086-1089
- https://doi.org/10.1124/dmd.31.9.1086
Abstract
Morphine elimination involves UDP-glucuronosyltransferase (UGT) catalyzed conjugation with glucuronic acid to form morphine 3- and 6-glucuronides (M3G and M6G, respectively). It has been proposed that UGT2B7 is the major enzyme involved in these reactions, but there is evidence to suggest that other isoforms also catalyze morphine glucuronidation in man. Thus, we have characterized the selectivity and kinetics of M3G and M6G formation by recombinant human UGTs. UGT 1A1, 1A3, 1A6, 1A8, 1A9, 1A10, and 2B7 all catalyzed M3G formation, but only UGT2B7 formed M6G. The kinetics of M3G formation by the UGT1A family isoforms was consistent with a single enzyme Michaelis-Menten model, with apparent Km values ranging from 2.6 to 37.4 mM. In contrast, M3G and M6G formation by UGT2B7 exhibited atypical kinetics. The atypical kinetics may be described by a model with high- and low-affinity Km values (0.42 and 8.3 mM for M3G, and 0.97 and 7.4 mM for M6G) from fitting to a biphasic Michaelis-Menten model. However, a multisite model with an interaction between two identical binding sites in a negative cooperative manner provides a more realistic approach to modeling these data. According to this model, the respective binding affinities (Ks) for M3G and M6G were 1.76 and 1.41 mM, respectively. These data suggest that M6G formation may be used as a selective probe for UGT2B7 activity, and morphine glucuronidation by UGT2B7 appears to involve the simultaneous binding of two substrate molecules, highlighting the need for careful analysis of morphine glucuronidation kinetics in vitro.Keywords
This publication has 12 references indexed in Scilit:
- Enzyme Kinetics of Cytochrome P450-Mediated ReactionsCurrent Drug Metabolism, 2012
- Quinidine and Haloperidol as Modifiers of CYP3A4 Activity: Multisite Kinetic Model ApproachDrug Metabolism and Disposition, 2002
- Atypical Kinetic Profiles in Drug Metabolism ReactionsDrug Metabolism and Disposition, 2002
- Human UDP-Glucuronosyltransferases: Metabolism, Expression, and DiseaseAnnual Review of Pharmacology and Toxicology, 2000
- Isolation and Characterization of a Human Orphan UDP-Glucuronosyltransferase, UGT2B11Biochemical and Biophysical Research Communications, 1998
- The Regio- and Stereo-Selectivity of C19 and C21 Hydroxysteroid Glucuronidation by UGT2B7 and UGT2B11Archives of Biochemistry and Biophysics, 1997
- The Disposition of Morphine and Its 3- and 6-Glucuronide Metabolites in Humans and Animals, and the Importance of the Metabolites to the Pharmacological Effects of MorphineDrug Metabolism Reviews, 1996
- cDNA Cloning and Expression of Two New Members of the Human Liver UDP-Glucuronosyltransferase 2B SubfamilyBiochemical and Biophysical Research Communications, 1993
- Drug glucuronidation in humansPharmacology & Therapeutics, 1991
- In vitro evidence for the involvement of at least two forms of human liver UDP-glucuronosyltransferase in morphine 3-glucuronidationBiochemical Pharmacology, 1988